Cannabis as Medicine

No Medication Has Been Proven to Treat Cannabis Use Disorder, Landmark Study Finds

Therapy, Not Tablets: The Real Picture of Cannabis Addiction Treatment The most comprehensive scientific review of its kind has found that no medication works for cannabis addiction treatment, while certain talking therapies offer more meaningful promise. The findings come from the journal Addiction, published in 2026, at a time when cannabis use disorder is rising worldwide […]

No Medication Has Been Proven to Treat Cannabis Use Disorder, Landmark Study Finds Read More »

Medical Cannabis and Mental Health: What the Latest Evidence Really Tells Us

A sweeping new study published in The Lancet Psychiatry has reignited a long-running debate about medical cannabis for mental health conditions. The findings make for uncomfortable reading for a fast-growing private prescribing sector that has largely outpaced the science behind it. Researchers described this as the largest and most comprehensive review of its kind. They analysed

Medical Cannabis and Mental Health: What the Latest Evidence Really Tells Us Read More »

Impact of Cannabis and Cannabis Legalization on US Atrial Septal Defect Rates

Impact of Cannabis and Cannabis Legalization on US Atrial Septal Defect Rates by  Albert Stuart Reece & Gary Kenneth Hulse – Division of Psychiatry, University of Western Australia, 35 Stirling Hwy., Crawley, WA 6009, Australia School of Medical and Health Sciences, Edith Cowan University, 27 Joondalup Dr., Joondalup, WA 6027, Australia Xenobiot.2026, 16(2), 43; https://doi.org/10.3390/jox16020043 Abstract Atrial

Impact of Cannabis and Cannabis Legalization on US Atrial Septal Defect Rates Read More »

Promising’ Cannabis Trial for Back Pain Sparks Limited Optimism Amid Safety Concerns – But Larger Studies Contradict.

‘A large phase 3 trial in Nature Medicine has delivered a ‘stronger’ clinical signal that a proprietary cannabis extract, VER-01, can modestly reduce chronic low back pain – but the effect is small, side effects are common, and broader evidence from other pain conditions remains weak and inconsistent. Experts say the findings should temper rather than fuel

Promising’ Cannabis Trial for Back Pain Sparks Limited Optimism Amid Safety Concerns – But Larger Studies Contradict. Read More »

Unlocking the Biological Impact of Developmental Cannabis and Its Psychiatric Risk

https://www.youtube.com/watch?v=7hXEUNnIhZU IASIC Speaker Series presents: Dr. Yasmin Hurd, an internationally recognized neuroscientist and leader in translational addiction research. In her talk, “Unlocking the Biological Impact of Developmental Cannabis and Its Psychiatric Risk,” Dr. Hurd will explore cutting-edge evidence on how cannabis exposure during critical developmental periods can alter brain biology and increase vulnerability to psychiatric

Unlocking the Biological Impact of Developmental Cannabis and Its Psychiatric Risk Read More »

Cannabis Users Face Six Times Higher Heart Attack Risk, New Research Shows

The conversation around cannabis has shifted dramatically over the past decade. As legalisation sweeps across nations and the substance becomes increasingly normalised, a troubling pattern has emerged in medical research that demands urgent attention. The link between cannabis and heart attack risk has become undeniable, with young, seemingly healthy adults experiencing cardiac events at rates

Cannabis Users Face Six Times Higher Heart Attack Risk, New Research Shows Read More »

JAMA Review Finds ‘Medicinal Cannabis’…Isn’t!

“For patients using cannabis or cannabinoids for treatment of medical conditions, clinicians should discuss harm reduction strategies, including avoiding concurrent use with alcohol or other central nervous system depressants such as benzodiazepines, using the lowest effective dose, and avoiding use when driving or operating machinery. Evidence from randomized clinical trials does not support the use

JAMA Review Finds ‘Medicinal Cannabis’…Isn’t! Read More »

Cannabis Legalization and Opioid Use Disorder in Veterans Health Administration Patients

Abstract Importance: In the context of the US opioid crisis, factors associated with the prevalence of opioid use disorder (OUD) must be identified to aid prevention and treatment. State medical cannabis laws (MCL) and recreational cannabis laws (RCL) are potential factors associated with OUD prevalence. Objective: To examine changes in OUD prevalence associated with MCL and RCL

Cannabis Legalization and Opioid Use Disorder in Veterans Health Administration Patients Read More »

Therapeutic Use of Cannabis: What Healthcare Professionals Need to Know About Risks

The therapeutic application of cannabis has become increasingly prevalent across developed nations, yet the scientific evidence supporting its medical use remains surprisingly limited. A recent JAMA Clinical Reviews podcast featuring Dr Kevin Hill from Harvard Medical School reveals critical information that healthcare professionals and patients need to understand about the therapeutic use of cannabis and

Therapeutic Use of Cannabis: What Healthcare Professionals Need to Know About Risks Read More »

Cannabis Therapeutic Evidence: Separating Scientific Facts from Marketing Claims

Recent national policy changes have made cannabis increasingly available for medical purposes across numerous conditions. Yet a significant gap exists between what’s approved for cannabis therapeutic use and what scientific evidence actually supports. Understanding this distinction is crucial for public health and informed decision-making. The FDA Approval Reality for Cannabis Therapeutic Use Despite widespread availability

Cannabis Therapeutic Evidence: Separating Scientific Facts from Marketing Claims Read More »

Scroll to Top